On January 21, 2019 the Federal Government implemented revised regulations that oversee research involving human participants (aka – The Revised Common Rule).

This page summarizes key variations in requirements and procedures that the UCLA OHRPP and investigators must adhere to for research approved, or determined exempt on or after January 21, 2019.

UCLA OHRPP Guidance has been updated to reflect the details of new and revised processes and will be released to campus as it is finalized. Of note, the Federal Government has provided limited guidance into interpreting the Revised Common Rule. As additional guidance is provided, we will continually update OHRPP guidance and procedure documents, and communicate key information to the research community as needed.

When the research invokes multiple regulatory frameworks (e.g., Common Rule, FDA, HIPAA), all will be applied following the procedures detailed in UCLA OHRPP Guidance and this memo.

Please note that this page and related documents will use the terminology “Pre-2018 Rule” for the Common Rule prior to January 21, 2019. “2018 Rule” or “Revised Common Rule” or “RCR” refers to the set of Federal Regulations for research approved on or after January 21, 2019. This terminology is consistent with Federal Regulations and guidance.

PrintExpand AllCollapse All

Page Last Updated: July 14, 2020